Education
About Us
Working with TipRanks
Follow Us
Peter A. Thompson Insider Profile
25 Followers
Peter A. Thompson, Director at Adaptimmune Therapeutics, holds 3.53M shares in Sionna Therapeutics, Inc. (Ticker: SION), holds 8.82M shares in Corvus Pharmaceuticals (Ticker: CRVS), holds 443.79K shares in Edgewise Therapeutics (Ticker: EWTX). Most recently, Peter A. Thompson Sold ― shares of Sionna Therapeutics, Inc. on Feb 04, 2026 for an estimated value of $1.38M.
Peter A. Thompson Adaptimmune Therapeutics (ADAPY)Director
Adaptimmune Therapeutics (ADAPY)
Director
Ranked #2,268 out of 106,013 Corporate Insiders
Profitable Transactions
23 out of 35 Profitable Transactions
Average Return
+23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter A. Thompson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter A. Thompson
Peter A. Thompson's Trading History
Adaptimmune Therapeutics
Jun 06, 2018
Director
Informative Sell
253.63K
$98.03K
Alpine Immune Sciences
May 20, 2024
―
Uninformative Sell
―
$0.00
Corvus Pharmaceuticals
Jan 30, 2026
Director, Ten Percent Owner
Uninformative Buy
1.12M
$161.04M
Thoratec Corp
Dec 13, 2018
―
Uninformative Buy
―
$337.59M
Synthorx
Jan 24, 2020
―
Uninformative Sell
361.51M
$0.00
Prevail Therapeutics
Jun 26, 2019
―
Uninformative Buy
―
$317.92M
PMV Pharmaceuticals
Sep 29, 2020
Director, Ten Percent Owner
Uninformative Buy
―
$193.87K
ARS Pharmaceuticals
Aug 28, 2024
Director
Informative Sell
1.09M
$76.92M
Decibel Therapeutics
Feb 19, 2021
―
Uninformative Buy
―
$4.34M
Edgewise Therapeutics
Apr 04, 2025
Director, Ten Percent Owner
Informative Buy
10.00M
$13.51M
Janux Therapeutics Inc
Dec 30, 2021
Director
Informative Sell
820.12K
$3.15M
Sionna Therapeutics, Inc.
Feb 04, 2026
Director
Informative Sell
1.38M
$129.01M
Anthera Pharmaceuticals
―
Director
―
―
Mirati Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter A. Thompson's performance on stock
You May Also Like
Peter A. Thompson insider profile FAQ
What is the percentage of profitable transactions made by Peter A. Thompson?
The percentage of profitable transactions made by Peter A. Thompson is 66%.
What is the average return per transaction made by Peter A. Thompson?
The average return per transaction made by Peter A. Thompson is 23.60%.
What stocks does Peter A. Thompson hold?
Peter A. Thompson holds: ADAPY, ALPN, CRVS, ~THOR, THOR, PRVL, PMVP, SPRY, DBTX, EWTX, JANX, SION, ANTH, MRTX stocks.
What was Peter A. Thompson’s latest transaction?
Peter A. Thompson latest transaction was an Informative Sell of $1.38M.
What was Peter A. Thompson's most profitable transaction?
Peter A. Thompson’s most profitable transaction was an Informative Buy of EWTX stock on April 4, 2025. The return on the trade was 154.60%.
What is Peter A. Thompson's role in Adaptimmune Therapeutics?
Peter A. Thompson's role in Adaptimmune Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.